BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22889736)

  • 1. Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?
    Xekouki P; Stratakis CA
    Endocr Relat Cancer; 2012 Dec; 19(6):C33-40. PubMed ID: 22889736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
    Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
    J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?
    Xekouki P; Pacak K; Almeida M; Wassif CA; Rustin P; Nesterova M; de la Luz Sierra M; Matro J; Ball E; Azevedo M; Horvath A; Lyssikatos C; Quezado M; Patronas N; Ferrando B; Pasini B; Lytras A; Tolis G; Stratakis CA
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E357-66. PubMed ID: 22170724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.
    Pitsava G; Settas N; Faucz FR; Stratakis CA
    Front Endocrinol (Lausanne); 2021; 12():680609. PubMed ID: 34012423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
    Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
    Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
    Imperiale A; Moussallieh FM; Roche P; Battini S; Cicek AE; Sebag F; Brunaud L; Barlier A; Elbayed K; Loundou A; Bachellier P; Goichot B; Stratakis CA; Pacak K; Namer IJ; Taïeb D
    Neoplasia; 2015 Jan; 17(1):55-65. PubMed ID: 25622899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
    Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
    MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
    Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
    Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
    Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
    Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rare forms of hereditary endocrine neoplasia: co-existence of pituitary adenoma and pheochromocytoma/paraganglioma].
    Mamedova EO; Lisina DV; Belaya ZE
    Probl Endokrinol (Mosk); 2023 May; 69(2):24-30. PubMed ID: 37448268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.
    O'Toole SM; Dénes J; Robledo M; Stratakis CA; Korbonits M
    Endocr Relat Cancer; 2015 Aug; 22(4):T105-22. PubMed ID: 26113600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
    Bayley JP; Devilee P; Taschner PE
    BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
    Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
    Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GROWTH RATE OF PARAGANGLIOMAS RELATED TO GERMLINE MUTATIONS OF THE SDHX GENES.
    Michałowska I; Ćwikła JB; Michalski W; Wyrwicz LS; Prejbisz A; Szperl M; Nieć D; Neumann HP; Januszewicz A; Pęczkowska M
    Endocr Pract; 2017 Mar; 23(3):342-352. PubMed ID: 27967220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.
    Lendvai N; Pawlosky R; Bullova P; Eisenhofer G; Patocs A; Veech RL; Pacak K
    Endocrinology; 2014 Jan; 155(1):27-32. PubMed ID: 24189137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
    Branzoli F; Salgues B; Marjańska M; Laloi-Michelin M; Herman P; Le Collen L; Delemer B; Riancho J; Kuhn E; Jublanc C; Burnichon N; Amar L; Favier J; Gimenez-Roqueplo AP; Buffet A; Lussey-Lepoutre C
    Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36449569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas.
    Mannelli M; Canu L; Ercolino T; Rapizzi E; Martinelli S; Parenti G; De Filpo G; Nesi G
    Eur J Endocrinol; 2018 Jan; 178(1):R11-R17. PubMed ID: 28924001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.